{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:08:25Z","timestamp":1762459705073,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11010-019-03525-8","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T08:03:40Z","timestamp":1555315420000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["SIRT6 abrogation promotes adrenocortical carcinoma through activation of NF-\u03baB signaling"],"prefix":"10.1007","volume":"458","author":[{"given":"Xueyi","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0180-3871","authenticated-orcid":false,"given":"Haoming","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,15]]},"reference":[{"key":"3525_CR1","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.1038\/s41467-018-06366-z","volume":"9","author":"SK Gara","year":"2018","unstructured":"Gara SK, Lack J, Zhang L, Harris E, Cam M et al (2018) Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors. Nat Commun 9:4172","journal-title":"Nat Commun"},{"key":"3525_CR2","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.surg.2018.07.026","volume":"164","author":"K Wu","year":"2018","unstructured":"Wu K, Liu Z, Liang J, Tang Y, Zou Z et al (2018) Laparoscopic versus open adrenalectomy for localized (stage 1\/2) adrenocortical carcinoma: experience at a single, high-volumecenter. Surgery 164:1325\u20131329","journal-title":"Surgery"},{"key":"3525_CR3","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-18-0608","volume":"179","author":"M Fassnacht","year":"2018","unstructured":"Fassnacht M, Dekkers OM, Else T, Baudin E, Berruti A et al (2018) European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 179:G1\u2013G46","journal-title":"Eur J Endocrinol"},{"key":"3525_CR4","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1245\/s10434-018-6754-5","volume":"25","author":"BS Miller","year":"2018","unstructured":"Miller BS (2018) Changes in the evaluation and management of adrenocortical carcinoma. Ann Surg Oncol 25:3413\u20133415","journal-title":"Ann Surg Oncol"},{"key":"3525_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00104-018-0712-4","volume":"90","author":"S Schimmack","year":"2018","unstructured":"Schimmack S, Strobel O (2018) [Resection strategies for adrenocortical carcinoma]. Chirurg 90:9\u201314","journal-title":"Chirurg"},{"key":"3525_CR6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s12020-011-9502-1","volume":"40","author":"YZ Xu","year":"2011","unstructured":"Xu YZ, Zhu Y, Shen ZJ, Sheng JY, He HC et al (2011) Significance of heparanase-1 and vascular endothelial growth factor in adrenocortical carcinoma angiogenesis: potential for therapy. Endocrine 40:445\u2013451","journal-title":"Endocrine"},{"key":"3525_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/936031","author":"TC Ribeiro","year":"2014","unstructured":"Ribeiro TC, Jorge AA, Almeida MQ, Mariani BM, Nishi MY et al (2014) Amplification of the insulin-like growth factor 1 receptor gene is a rare event in adrenocortical adenocarcinomas: searching for potential mechanisms of overexpression. Biomed Res Int. https:\/\/doi.org\/10.1155\/2014\/936031","journal-title":"Biomed Res Int"},{"key":"3525_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/jcb.27128","volume":"120","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Tu W, Tian K, Han L, Wang Q et al (2018) Sirtuin 6 inhibits myofibroblast differentiation via inactivating transforming growth factor-beta1\/Smad2 and nuclear factor-kappaB signaling pathways in human fetal lung fibroblasts. J Cell Biochem 120:93\u2013104","journal-title":"J Cell Biochem"},{"key":"3525_CR9","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1038\/s41598-018-22388-5","volume":"8","author":"M Rahnasto-Rilla","year":"2018","unstructured":"Rahnasto-Rilla M, Tyni J, Huovinen M, Jarho E, Kulikowicz T et al (2018) Natural polyphenols as sirtuin 6 modulators. Sci Rep 8:4163","journal-title":"Sci Rep"},{"key":"3525_CR10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.2119\/molmed.2017.00085","volume":"23","author":"F Liu","year":"2017","unstructured":"Liu F, Bu HF, Geng H, De Plaen IG, Gao C et al (2017) Sirtuin-6 preserves R-spondin-1 expression and increases resistance of intestinal epithelium to injury in mice. Mol Med 23:272\u2013284","journal-title":"Mol Med"},{"key":"3525_CR11","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.1111\/bph.14428","volume":"175","author":"Y Hu","year":"2018","unstructured":"Hu Y, Tao X, Han X, Xu L, Yin L et al (2018) MicroRNA-351-5p aggravates intestinal ischaemia\/reperfusion injury through the targeting of MAPK13 and Sirtuin-6. Br J Pharmacol 175:3594\u20133609","journal-title":"Br J Pharmacol"},{"key":"3525_CR12","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.bbrc.2018.07.057","volume":"503","author":"JH Kim","year":"2018","unstructured":"Kim JH, Lee JM, Kim JH, Kim KR (2018) Fluvastatin activates sirtuin 6 to regulate sterol regulatory element-binding proteins and AMP-activated protein kinase in HepG2 cells. Biochem Biophys Res Commun 503:1415\u20131421","journal-title":"Biochem Biophys Res Commun"},{"key":"3525_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s12031-017-1005-y","volume":"64","author":"NN Mohamad","year":"2018","unstructured":"Mohamad NN, Zainuddin A, Shamsuddin S (2018) Emerging roles of Sirtuin 6 in Alzheimer\u2019s disease. J Mol Neurosci 64:157\u2013161","journal-title":"J Mol Neurosci"},{"key":"3525_CR14","doi-asserted-by":"crossref","first-page":"76223","DOI":"10.18632\/oncotarget.19297","volume":"8","author":"Y Wang","year":"2017","unstructured":"Wang Y, Pan T, Wang H, Li L, Li J et al (2017) Overexpression of SIRT6 attenuates the tumorigenicity of hepatocellular carcinoma cells. Oncotarget 8:76223\u201376230","journal-title":"Oncotarget"},{"key":"3525_CR15","doi-asserted-by":"crossref","first-page":"40377","DOI":"10.18632\/oncotarget.9750","volume":"7","author":"L Bai","year":"2016","unstructured":"Bai L, Lin G, Sun L, Liu Y, Huang X et al (2016) Upregulation of SIRT6 predicts poor prognosis and promotes metastasis of non-small cell lung cancer via the ERK1\/2\/MMP9 pathway. Oncotarget 7:40377\u201340386","journal-title":"Oncotarget"},{"key":"3525_CR16","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.cell.2012.10.047","volume":"151","author":"C Sebastian","year":"2012","unstructured":"Sebastian C, Zwaans BM, Silberman DM, Gymrek M, Goren A et al (2012) The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 151:1185\u20131199","journal-title":"Cell"},{"key":"3525_CR17","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1016\/j.febslet.2015.06.043","volume":"589","author":"T Fukuda","year":"2015","unstructured":"Fukuda T, Wada-Hiraike O, Oda K, Tanikawa M, Makii C et al (2015) Putative tumor suppression function of SIRT6 in endometrial cancer. FEBS Lett 589:2274\u20132281","journal-title":"FEBS Lett"},{"key":"3525_CR18","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.celrep.2013.11.029","volume":"5","author":"Z Lin","year":"2013","unstructured":"Lin Z, Yang H, Tan C, Li J, Liu Z et al (2013) USP10 antagonizes c-Myc transcriptional activation through SIRT6 stabilization to suppress tumor formation. Cell Rep 5:1639\u20131649","journal-title":"Cell Rep"},{"issue":"Suppl 3","key":"3525_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2362.2000.0300s3001.x","volume":"30","author":"C Marx","year":"2000","unstructured":"Marx C, Bornstein SR, Wolkersdorfer GW (2000) Cellular immune-endocrine interaction in adrenocortical tissues. Eur J Clin Invest 30(Suppl 3):1\u20135","journal-title":"Eur J Clin Invest"},{"key":"3525_CR20","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2018.4304","author":"N Li","year":"2018","unstructured":"Li N, Mao D, Cao Y, Li H, Ren F et al (2018) Downregulation of SIRT6 by miR-34c-5p is associated with poor prognosis and promotes colon cancer proliferation through inhibiting apoptosis via the JAK2\/STAT3 signaling pathway. Int J Oncol. https:\/\/doi.org\/10.3892\/ijo.2018.4304","journal-title":"Int J Oncol"},{"key":"3525_CR21","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1177\/0300060517750298","volume":"46","author":"B Zhu","year":"2018","unstructured":"Zhu B, Yan Y, Shao B, Tian L, Zhou W (2018) Downregulation of SIRT6 is associated with poor prognosis in patients with non-small cell lung cancer. J Int Med Res 46:1517\u20131527","journal-title":"J Int Med Res"},{"key":"3525_CR22","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1158\/1078-0432.CCR-15-1638","volume":"22","author":"LK Ran","year":"2016","unstructured":"Ran LK, Chen Y, Zhang ZZ, Tao NN, Ren JH et al (2016) SIRT6 overexpression potentiates apoptosis evasion in hepatocellular carcinoma via BCL2-associated X protein-dependent apoptotic pathway. Clin Cancer Res 22:3372\u20133382","journal-title":"Clin Cancer Res"},{"key":"3525_CR23","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/2211-5463.12265","volume":"7","author":"H Lin","year":"2017","unstructured":"Lin H, Hao Y, Zhao Z, Tong Y (2017) Sirtuin 6 contributes to migration and invasion of osteosarcoma cells via the ERK1\/2\/MMP9 pathway. FEBS Open Bio 7:1291\u20131301","journal-title":"FEBS Open Bio"},{"key":"3525_CR24","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3892\/or.2017.5753","volume":"38","author":"J Zhou","year":"2017","unstructured":"Zhou J, Wu A, Yu X, Zhu J, Dai H (2017) SIRT6 inhibits growth of gastric cancer by inhibiting JAK2\/STAT3 pathway. Oncol Rep 38:1059\u20131066","journal-title":"Oncol Rep"},{"key":"3525_CR25","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.celrep.2017.01.065","volume":"18","author":"RM Ioris","year":"2017","unstructured":"Ioris RM, Galie M, Ramadori G, Anderson JG, Charollais A et al (2017) SIRT6 suppresses cancer stem-like capacity in tumors with PI3K activation independently of its deacetylase activity. Cell Rep 18:1858\u20131868","journal-title":"Cell Rep"},{"key":"3525_CR26","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.4161\/cc.10.18.17435","volume":"10","author":"M Meter Van","year":"2011","unstructured":"Van Meter M, Mao Z, Gorbunova V, Seluanov A (2011) SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells. Cell Cycle 10:3153\u20133158","journal-title":"Cell Cycle"},{"key":"3525_CR27","first-page":"e165835","volume":"11","author":"N Lee","year":"2016","unstructured":"Lee N, Ryu HG, Kwon JH, Kim DK, Kim SR et al (2016) SIRT6 depletion suppresses tumor growth by promoting cellular senescence induced by DNA damage in HCC. PLoS ONE 11:e165835","journal-title":"PLoS ONE"},{"key":"3525_CR28","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3390\/cancers10100352","volume":"10","author":"N Khurana","year":"2018","unstructured":"Khurana N, Sikka SC (2018) Targeting crosstalk between Nrf-2, NF-kappaB and androgen receptor signaling in prostate cancer. Cancers (Basel) 10:352","journal-title":"Cancers (Basel)"},{"key":"3525_CR29","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.3390\/ijms19092733","volume":"19","author":"A Nicolini","year":"2018","unstructured":"Nicolini A, Ferrari P, Diodati L, Carpi A (2018) Alterations of signaling pathways related to the immune system in breast cancer: new perspectives in patient management. Int J Mol Sci 19:2733","journal-title":"Int J Mol Sci"},{"key":"3525_CR30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.suronc.2018.05.003","volume":"27","author":"H Zhao","year":"2018","unstructured":"Zhao H, Xu J, Wang Y, Jiang R, Li X et al (2018) Knockdown of CEACAM19 suppresses human gastric cancer through inhibition of PI3K\/Akt and NF-kappaB. Surg Oncol 27:495\u2013502","journal-title":"Surg Oncol"},{"key":"3525_CR31","first-page":"2241","volume":"53","author":"F Liu","year":"2018","unstructured":"Liu F, Cheng L, Xu J, Guo F, Chen W (2018) miR-17-92 functions as an oncogene and modulates NF-kappaB signaling by targeting TRAF3 in MGC-803 human gastric cancer cells. Int J Oncol 53:2241\u20132257","journal-title":"Int J Oncol"},{"key":"3525_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.27535","author":"Z Wang","year":"2018","unstructured":"Wang Z, Lu Y, Sheng B, Ding Y, Cheng X (2018) Catalpol inhibits TGF-beta1-induced epithelial-mesenchymal transition in human non-small-cell lung cancer cells through the inactivation of Smad2\/3 and NF-kappaB signaling pathways. J Cell Biochem. https:\/\/doi.org\/10.1002\/jcb.27535","journal-title":"J Cell Biochem"},{"key":"3525_CR33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7555\/JBR.32.20180035","volume":"32","author":"HB Tong","year":"2018","unstructured":"Tong HB, Zou CL, Qin SY, Meng J, Keller ET et al (2018) Prostate cancer tends to metastasize in the bone-mimicking microenvironment via activating NF-kappaB signaling. J Biomed Res 32:343\u2013353","journal-title":"J Biomed Res"},{"key":"3525_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cells7090122","author":"J Staal","year":"2018","unstructured":"Staal J, Beyaert R (2018) Inflammation and NF-kappaB signaling in prostate cancer: mechanisms and clinical implications. Cells. https:\/\/doi.org\/10.3390\/cells7090122","journal-title":"Cells"},{"key":"3525_CR35","doi-asserted-by":"publisher","DOI":"10.2174\/1574888X13666180723104340","author":"C Tang","year":"2018","unstructured":"Tang C, Zhu G (2018) Classic and novel signaling pathways involved cancer: targeting the NF-kappaB and Syk signaling pathways. Curr Stem Cell Res Ther. https:\/\/doi.org\/10.2174\/1574888X13666180723104340","journal-title":"Curr Stem Cell Res Ther"},{"key":"3525_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10911-018-9404-4","volume":"23","author":"J Harquail","year":"2018","unstructured":"Harquail J, LeBlanc N, Landry C, Crapoulet N, Robichaud GA (2018) Pax-5 Inhibits NF-kappaB activity in breast cancer cells through IKKepsilon and miRNA-155 effectors. J Mammary Gland Biol Neoplasia 23:177\u2013187","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"2","key":"3525_CR37","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/biomedicines6020066","volume":"6","author":"M Tegowski","year":"2018","unstructured":"Tegowski M, Baldwin A (2018) Noncanonical NF-kappaB in cancer. Biomedicines 6(2):66","journal-title":"Biomedicines"},{"key":"3525_CR38","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11010-018-3365-1","volume":"449","author":"B Liu","year":"2018","unstructured":"Liu B, Xu T, Xu X, Cui Y, Xing X (2018) Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-kappaB signal transduction. Mol Cell Biochem 449:285\u2013294","journal-title":"Mol Cell Biochem"},{"key":"3525_CR39","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1186\/s12885-018-4507-2","volume":"18","author":"CD House","year":"2018","unstructured":"House CD, Grajales V, Ozaki M, Jordan E, Wubneh H et al (2018) IKappaKappaepsilon cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts. BMC Cancer 18:595","journal-title":"BMC Cancer"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03525-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-019-03525-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03525-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T19:04:44Z","timestamp":1694804684000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-019-03525-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,15]]},"references-count":39,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["3525"],"URL":"https:\/\/doi.org\/10.1007\/s11010-019-03525-8","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"type":"print","value":"0300-8177"},{"type":"electronic","value":"1573-4919"}],"subject":[],"published":{"date-parts":[[2019,4,15]]},"assertion":[{"value":"13 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study has been approved by the Ethics Committee of the West China Hospital, Sichuan University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}